JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2025 ,inter alia, to consider and approve inter-alia, the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2024.